Supplementary Table 3. Gene list mapped to the Affymetrix Human Genome U133A  focusing on gene sets ES exp1  PRC2 targets  NOS targets  and Myc targets

Table 2. Lipid peroxidation gene-based global  trend  and haplowalkminimum P values for associations with
kidney cancer risk

Table 2. Inflammatory mediator inhibition by dexamethasone  shown as fold change  in unstimulated and CSE stimulated COPD MDMs

Additional File 2. Genes significant by different methods of analysis of the microarray data.

Table 2. Hypoxia gene signature; well characterized genes related to angiogenesis  apoptosis  glycolysis  and metabolism that are known to be induced by hypoxia in cells of different lineage

Table 2. Description of the 44 prognostic genes of the metagene associated with survival. The genes were refined using 4 independent data sets

Table S1. Genes with differential expression on univariate analysis between cytogenetic responders and non-responders

Supplementary Table 3:  Genomic classifier based on the the GAB2-signature discriminating breast cancer patients with good and poor prognosis

Supplementary Table 1: The Gab2-Signature in MCF10A Cells

Supplementary Table 2: Affymetrix probe sets corresponding to the GAB2-signature and their Pearson correlation with sensitivity (GI-50) to Resveratrol  Piceatannol and SD-1029 in the NCI-60 cell line panel.

TABLE 1. Up-regulated (increased expression of 2.0 or more) Genes in SHED (stem cells from human exfoliated deciduous teeth)

TABLE 2. Down-regulated (decreased expression of 2.0 fold or more) Genes in SHED (stem cells from human exfoliated deciduous teeth)

Table S5. Differentially-expressed genes throughout development; Multiple genes were significantly (p<0.01  at least two-fold) differentially-expressed between these stages when considerably more genes were upregulated (1908 probe sets  1509 mapped genes) than downregulated (432 probe sets  301 mapped genes) in the later stage compared to the earlier one

Supplemental Table 1. Gene expression values of 2134 gene probe sets corresponding to 1742 genes that discriminated ARPCs from RPTEC and MSC.    P < 0.0001  false discovery rate (FDR) < 5%.